Piramal Pharma Solutions Inc. today announced plans to expand its current Lexington operations with a nearly $80 million ...

Piramal's global Contract Development and Manufacturing Organization plans to more than double the facility’s capacity by Q1 ...

As the efficiency and efficacy of injectable treatment options improve, more patients are expected to benefit from advanced therapies.

The expansion will equip the Lexington site with an additional 24,000 square feet of manufacturing space, a new lab, and ...

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of ...

Piramal Pharma Solutions invests $80 million in Lexington facility expansion to meet growing demand in injectables market.

Piramal Pharma’s stock price rose 2% in the opening trading on September 30 after the business received an Establishment ...

In July 2024, the USFDA inspected the said facility with Zero Form - 483 observations and No Action Indicated (NAI) ...

Piramal Pharma, chaired by Nandini Piramal, aims to become a global pharma and wellness giant exceeding $2 billion by FY30.

Nandini Piramal has earned an MBA from Stanford University Graduate School of Business, California. She also holds a Bachelor ...

Isha Ambani Piramal stepped into the spotlight at the Business of Fashion (BOF) Gala in Paris, dressed in a breathtaking ...

Mumbai: Piramal Pharma has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA ...